SCHEMBL7546940

SCHEMBL7546940

COC(=O)c1cccc2c1c(-c1cncc(-c3ccc(OC)cc3)c1)cn2CCCN1CCN(C)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 3/20 0.49
FLT1 P17948 2/20 0.49
FLT4 P35916 2/20 0.49
GSK3B P49841 3/20 0.42
QPCT Q16769 2/20 0.42
SMYD2 Q9NRG4 2/20 0.39
MAPT P10636 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
MAP3K11 Q16584 1/20 0.39
KDM5B Q9UGL1 1/20 0.39
TP53 P04637 1/20 0.39
GABRA1 P14867 1/20 0.39
GABRG2 P18507 1/20 0.39
GABRB3 P28472 1/20 0.39
GABRA3 P34903 1/20 0.39
GABRA2 P47869 1/20 0.39
EGFR P00533 1/20 0.38
FGFR1 P11362 1/20 0.38
FGFR2 P21802 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7551275 0.93 KDR (0.47) KDRFLT1FLT4GSK3BQPCT
SCHEMBL7550186 0.93 KDR (0.49) KDRFLT1FLT4GSK3BQPCT
SCHEMBL7554304 0.93 KDR (0.54) KDRFLT1FLT4GSK3BQPCT
SCHEMBL7551283 0.92 KDR (0.49) KDRFLT1FLT4GSK3BQPCT
SCHEMBL7994209 0.88 KDR (0.46) KDRFLT1FLT4SMYD2MAPT
SCHEMBL7547530 0.88 KDR (0.49) KDRFLT1FLT4GSK3BQPCT
SCHEMBL7553945 0.88 KDR (0.66) KDRFLT1FLT4GSK3BQPCT
SCHEMBL7976639 0.88 FLT1 (0.47) KDRFLT1FLT4GSK3BKDM5B
SCHEMBL7549814 0.86 FLT1 (0.47) KDRFLT1FLT4SMYD2ALDH1A1
SCHEMBL7549576 0.86 KDR (0.51) KDRFLT1FLT4GSK3BQPCT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1147107-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2002-05-22 EP claimed
EP-1147107-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-10-24 EP claimed
WO-2000043393-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-07-27 WO claimed
US-6265403-B1 TYROSINE INHIBITORS MERCK & CO., INC. 2001-07-24 US disclosed